abstract |
The invention relates to the association of a short-acting hypnotic agent chosen from a modulator of GABA-A receptors, a benzodiazepine, a phenothiazine, a derivative of melatonin and a melatonin receptor agonist, and of a long-acting hypnotic agent chosen from a modulator of the GABA-A receptors. |